Medical Devices Today

Biomet buys biomaterials fim Cartilix

Deal summary reprinted from Strategic Transactions - October 2009

Reconstructive device firm Biomet is acquiring fellow private company Cartilix (biomaterials) for an undisclosed amount. Read more...

Device Opportunities in the Diabetes Treatment Market

Article preview reprinted from Medtech Insight -September/October 2009

Diabetes is one of the top medical priorities in the world, and government and health care professionals are focused on finding therapies and technologies to battle the condition. Those efforts, plus the accompanying realization that treating diabetes is one of the best ways to reduce costs in overburdened health care systems, have created a very receptive market for new drugs and devices that can help achieve this goal. Read more...

SpinalMotion: Chapter 2 in Artificial Discs

Article preview reprinted from IN VIVO -  September/October, 2009 

SpinalMotion is one of a small number of second-generation companies that hope to follow in the path of the first artificial disc companies, with novel technologies and a more measured assessment of the market, especially the lumbar disc segment. The ultimate challenge for SpinalMotion may not be gaining market share, but finding an appropriate exit for its investors. Read more...

Cardiology Practices Hit By Changes In Medicare Physician Fee Schedule

Full article reprinted from "The Gray Sheet" - November 9, 2009

The American College of Cardiology will fight reimbursement cuts to cardiology practices imposed by the 2010 Medicare physician fee schedule that CMS finalized Oct. 30. Read more...

FDA Transparency Task Force Tackles Information Disclosure Challenges

Full article reprinted from "The Gray Sheet" - November 9, 2009

FDA has questions about whether to disclose information on product applications that a company abandons before approval or in some cases on applications in which review is still pending. Read more...

GE, Other MRI, CT Scan Makers Face Less Use Under New Medicare Rules

 

  

Covidien CEO Credits 2002 Tyco Scandal For Now Being Device Giant

St. Jude, Medtronic, Others Rely Heavily On Former Fishing-Lure Maker

Zimmer Request For New Use For Dynesys Hangs On FDA Staff Query

Boston Sci Gets EU Promus Element Approval Before Abbott Deal Ends

Boston Sci, Medtronic, Others Pressed By Hospitals On Price Opacity

Stryker Indicted By Federal Grand Jury For Fraud In Device Case

Medtronic Named In Suit Against Clinic For Surgeon Firing Over Stent Use

J&J’s Job Cuts Signal Slower Recovery For Medical-Device Industry

Medtronic Unapproved Heart Valve Implanted In Child With H1N1 Flu

 

Series A nails down $2.5mm for Keraderm

Deal summary reprinted from Strategic Transactions - October 2009

Phototherapy device developer Keraderm raised $2.5mm in its Series A financing round to NewVa Capital Partners, which is managed by Third Security.

Wireless Health: Personalized Medicine Comes to the Device Industry

Full article reprinted from Start Up - September/October 2009

This is the device industry's wireless wake-up call. With all the speed and acceleration of an advancing information technology industry, forces outside of the medical device industry are driving shifts in medical product markets and business models. Those forces include the consumerization. globalization, systematization, and economies of scale created by IT. Wireless medicine enables connectivity between caregivers and patients, continuous monitoring of patients with chronic diseases, and a new paradigm for personalized medicine, one based on the patterns that can be gleaned from enormous volumes of individualized patient data, rather than on blood-based biomarkers. Read more...

Device Companies Look Far and Wide for New Capital

Article preview reprinted from IN VIVO -  September/October, 2009 

The global recession that struck last September drove many device investors into hiding. This left a barren financial landscape for device companies to subsist on. But some are finding the funds they need, and they're sharing their survival stories. Read more...

Ideal Acquisition Candidates Are Advanced-Stage With Good Data - IN3 Panel

Full article reprinted from "The Gray Sheet" - November 2, 2009

The most desirable acquisition candidates for established medical technology firms in the current economic climate are those in advanced stages of development with good comparative effectiveness data, according to panelists at the recent Investment In Innovation (IN3) Medical Device Summit. Read more...